Inspire Medical Systems, Inc. - Common stock, par value $0.001 per share (INSP) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2018 to Q4 2025

Type / Class
Equity / Common stock, par value $0.001 per share
Symbol
INSP on NYSE
Shares outstanding
29,061,083
Price per share
$92.23
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
31,093,078
Total reported value
$2,308,572,740
% of total 13F portfolios
0%
Share change
-3,214,729
Value change
-$491,054,295
Number of holders
319
Price from insider filings
$92.23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Inspire Medical Systems, Inc. - Common stock, par value $0.001 per share (INSP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11% -10% $248,822,799 -$29,612,330 3,353,407 -11% BlackRock, Inc. 30 Sep 2025
CITADEL ADVISORS LLC 5.8% $127,107,716 1,713,042 Kenneth Griffin 29 Sep 2025
Flynn James E 5.1% $109,541,683 1,476,303 Deerfield Mgmt, L.P. 06 Nov 2025
FMR LLC 2.5% -72% $55,005,358 -$130,571,372 741,312 -70% FMR LLC 30 Sep 2025
WASATCH ADVISORS LP 0.5% -92% $10,084,819 -$103,003,921 135,914 -91% Wasatch Advisors LP 30 Sep 2025

As of 30 Sep 2025, 319 institutional investors reported holding 31,093,078 shares of Inspire Medical Systems, Inc. - Common stock, par value $0.001 per share (INSP). This represents 107% of the company’s total 29,061,083 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Inspire Medical Systems, Inc. - Common stock, par value $0.001 per share (INSP) together control 76% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 3,547,195 -8.4% 0% $263,201,869
VANGUARD GROUP INC 10% 3,000,087 -6.4% 0% $222,606,456
CITADEL ADVISORS LLC 6% 1,748,409 +20055% 0.1% $129,731,948
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 4.5% 1,297,573 +69% 0.25% $96,279,917
BAILLIE GIFFORD & CO 3.7% 1,084,350 -2.7% 0.06% $80,458,771
DEERFIELD MANAGEMENT COMPANY, L.P. 3.6% 1,047,694 +648% 1.2% $77,738,895
STATE STREET CORP 3.4% 979,309 -5% 0% $72,664,728
BRAIDWELL LP 3% 883,747 +69% 1.9% $65,574,027
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 2.9% 833,599 +37% 0.01% $61,853,047
FMR LLC 2.6% 749,312 -67% 0% $55,598,958
Soleus Capital Management, L.P. 2.5% 728,188 +568% 2.9% $54,031,550
JANUS HENDERSON GROUP PLC 2.3% 667,078 +4.1% 0.02% $49,496,529
Balyasny Asset Management L.P. 2.1% 614,359 0.09% $45,585,438
Artisan Partners Limited Partnership 1.8% 526,242 +45% 0.06% $39,047,156
BNP PARIBAS FINANCIAL MARKETS 1.8% 522,180 0% 0.03% $38,745,756
GEODE CAPITAL MANAGEMENT, LLC 1.7% 504,987 -1.5% 0% $37,476,743
UBS Group AG 1.6% 467,736 +8.6% 0.01% $34,706,011
MORGAN STANLEY 1.6% 450,641 +49% 0% $33,437,643
Champlain Investment Partners, LLC 1.4% 407,059 -1.2% 0.23% $30,203,778
Aberdeen Group plc 1.4% 396,340 +63% 0.05% $29,967,267
D. E. Shaw & Co., Inc. 1.2% 358,857 +2423% 0.02% $26,627,189
MILLENNIUM MANAGEMENT LLC 1.2% 356,808 0.02% $26,475,154
DIMENSIONAL FUND ADVISORS LP 1.2% 343,718 -0.33% 0.01% $25,506,313
FRANKLIN RESOURCES INC 1% 297,245 +30% 0.01% $22,055,613
BANK OF AMERICA CORP /DE/ 0.99% 288,828 +14% 0% $21,431,039

Institutional Holders of Inspire Medical Systems, Inc. - Common stock, par value $0.001 per share (INSP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,080,661 $99,676,874 +$38,384,647 $92.23 30
2025 Q3 31,093,078 $2,308,572,740 -$491,054,295 $74.20 319
2025 Q2 33,831,801 $4,392,084,401 -$58,153,296 $129.77 355
2025 Q1 34,119,574 $5,429,765,770 +$100,291,872 $159.28 359
2024 Q4 33,398,911 $6,198,135,879 -$10,392,454 $185.38 352
2024 Q3 33,329,348 $7,028,206,302 -$1,705,882 $211.05 343
2024 Q2 31,606,997 $4,230,734,481 -$140,076,478 $133.83 320
2024 Q1 31,802,382 $6,833,627,583 +$185,419,402 $214.79 324
2023 Q4 31,022,012 $6,309,755,960 +$504,375,008 $203.43 344
2023 Q3 28,380,805 $5,631,853,601 -$36,280,954 $198.44 356
2023 Q2 27,993,926 $9,086,637,911 -$98,840,711 $324.64 401
2023 Q1 28,513,136 $6,673,582,259 +$65,144,358 $234.07 368
2022 Q4 28,312,278 $7,130,563,019 +$41,625,853 $251.88 333
2022 Q3 28,267,105 $5,016,328,749 +$139,991,536 $177.37 292
2022 Q2 27,431,317 $5,013,352,590 +$89,018,351 $182.67 276
2022 Q1 26,955,412 $6,916,191,060 +$287,047,237 $256.69 291
2021 Q4 25,849,229 $5,947,709,044 +$76,974,096 $230.06 283
2021 Q3 25,385,159 $5,911,432,728 +$104,134,188 $232.88 247
2021 Q2 24,992,220 $4,831,725,707 -$34,514,146 $193.26 246
2021 Q1 25,166,568 $5,209,155,369 +$94,545,681 $206.99 247
2020 Q4 25,155,650 $4,731,720,287 -$140,415,322 $188.09 237
2020 Q3 26,177,389 $3,378,475,696 -$39,929,859 $129.05 201
2020 Q2 26,892,329 $2,354,092,452 +$328,506,311 $87.02 186
2020 Q1 23,290,616 $1,403,659,501 -$140,442,230 $60.28 166
2019 Q4 22,240,719 $1,650,480,334 +$34,675,200 $74.21 169
2019 Q3 21,815,581 $1,331,183,700 +$112,850,027 $61.02 153
2019 Q2 19,969,050 $1,211,118,776 +$171,165,829 $60.65 145
2019 Q1 17,810,823 $1,011,266,751 +$172,131,617 $56.78 143
2018 Q4 14,874,625 $628,449,909 +$162,990,460 $42.25 102
2018 Q3 9,259,018 $389,611,304 -$2,907,456 $42.08 85
2018 Q2 9,448,509 $336,936,129 +$336,926,999 $35.66 75